Yemima Berman

Yemima Berman

Auto-generated profile, based on publicly available information

Yemima Berman

Department of Clinical Genetics Royal North Shore Hospital St Leonards New South Wales Australia

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 August 2021 in Neurology
Verified
Journal Article
Closed access
PDF file
SMSheilagh Maguiness
Sheilagh Maguiness
YBYemima Berman
Yemima Berman
NRNathan Rubin
Nathan Rubin
MDMelissa Dodds
Melissa Dodds
Scott PlotkinScott Plotkin
Scott Plotkin
OCon behalf of the REiNS International Collaboration
on behalf of the REiNS International Collaboration
Objective In order to explore the use of Skindex scoring in patients with neurofibromatosis type 1 (NF1) across multiple clinical sites and inform design of additional quality of life measures, we analyzed correlations between Skindex, site, and clinical measures for 79 patients with NF1 from specialized clinics in Sydney, Australia (Royal North Shore Hospital [RNS]) and Minneapolis, Minnesota (University of Minnesota [UMN]). Methods The relationship between clinical factors and Skindex scores were explored by clinic site and overall. Results A total of 40 participants were recruited from RNS and 39 from UMN. Female sex, total number of cutaneous neurofibroma (cNF), and whether cNF were present on the face correlated highly with Skindex and not Riccardi scores. The UMN site had lower average scores, but these differences were almost entirely removed after adjusting for age, sex, facial cNF, and total cNF number. Conclusions The development of cNF in adolescence and adulthood in NF1 often leads to progressive disfigurement and discomfort and is among one of the most common reasons for patients to seek medical treatment. Skindex has been used to assess skin-related quality of life in NF1 previously but is not specific to NF1. These findings highlight the need for a low threshold for referral to dermatologists for all patients with NF1 regardless of the severity of disease. The finding that facial cNF and higher total number of cNF correlates with poorer skin-related quality of life may benefit design of more specific NF1 skin-related quality of life measures.

7 July 2015 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
HCH.A. Crawford
H.A. Crawford
BBBelinda Barton
Belinda Barton
MWMeredith J Wilson
Meredith J Wilson
YBYemima Berman
Yemima Berman
VMValerie McKelvey‐Martin
Valerie McKelvey‐Martin
Kathryn N. NorthKathryn N. North
Kathryn N. North

17 June 2023 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
YLYingjoy Li
Yingjoy Li
JBJaishri O. Blakeley
Jaishri O. Blakeley
ILIna Ly
Ina Ly
YBYemima Berman
Yemima Berman
JLJonathan Lau
Jonathan Lau
KKKristen M. Kelly
Kristen M. Kelly

28 November 2022 in Molecular Genetics & Genomic Medicine
Verified
Journal Article
Open access
JFJane Fleming
Jane Fleming
OMOliver Morgan
Oliver Morgan
CWClaire Wong
Claire Wong
TSTimothy E. Schlub
Timothy E. Schlub
YBYemima Berman
Yemima Berman
Background: Neurofibromatosis 1 (NF1) is a common cancer predisposition syndrome. Affected individuals require lifelong surveillance and often suffer progressive disfigurement due to cutaneous neurofibromas. The aim of this research was to characterize health concerns and quality of life (QOL) in a population cohort.Methods: An online survey was completed by 68 adults and 32 parents of children with NF1, and 60 controls. The survey included the Skindex‐29 QOL scale, 5D‐itch scale, and additional health questions.Results: Frequency of itch was high in children (50%) and adults (69%), with most expressing interest in treatment for itch. The presence of itch and increased visibility of NF1 were predictors of poorer QoL. Many adults (53%) and parents (44%) desired access to treatment to improve cosmetic appearance. Muscle weakness/tiredness was also prevalent amongst (60–70%) adults and children with NF1. Two‐thirds of adults with NF1 reported limited awareness of NF1 services and poor knowledge of surveillance, particularly breast screening in young women.Conclusion: This study highlights the impact of NF1‐related itch and visibility in adults and children with a need for cosmetic and itch treatment. The findings emphasize a need for strategies to promote awareness, and access to management and treatment of NF1 in adults.

26 November 2024 in Journal of Genetic Counseling
Verified
Journal Article
Closed access
TGTina Gonzalez
Tina Gonzalez
AMAlison McLean
Alison McLean
JFJane Fleming
Jane Fleming
KMKatrina Morris
Katrina Morris
MPMelissa Pacque
Melissa Pacque
YBYemima Berman
Yemima Berman

8 May 2021 in Familial Cancer
Verified
Journal Article
Closed access
PDF file
ACAshley Crook
Ashley Crook
RKRebekah Kwa
Rebekah Kwa
SESarah Ephraums
Sarah Ephraums
MWMathilda Wilding
Mathilda Wilding
LTLavvina Thiyagarajan
Lavvina Thiyagarajan
YBYemima Berman
Yemima Berman